1. Home
  2. GLAD vs CTKB Comparison

GLAD vs CTKB Comparison

Compare GLAD & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLAD
  • CTKB
  • Stock Information
  • Founded
  • GLAD 2001
  • CTKB 1990
  • Country
  • GLAD United States
  • CTKB United States
  • Employees
  • GLAD N/A
  • CTKB N/A
  • Industry
  • GLAD Finance/Investors Services
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • GLAD Finance
  • CTKB Health Care
  • Exchange
  • GLAD Nasdaq
  • CTKB Nasdaq
  • Market Cap
  • GLAD 612.5M
  • CTKB 526.7M
  • IPO Year
  • GLAD N/A
  • CTKB 2021
  • Fundamental
  • Price
  • GLAD $26.05
  • CTKB $4.02
  • Analyst Decision
  • GLAD Hold
  • CTKB Hold
  • Analyst Count
  • GLAD 3
  • CTKB 4
  • Target Price
  • GLAD $24.83
  • CTKB $6.00
  • AVG Volume (30 Days)
  • GLAD 94.9K
  • CTKB 1.0M
  • Earning Date
  • GLAD 08-04-2025
  • CTKB 11-04-2025
  • Dividend Yield
  • GLAD 7.60%
  • CTKB N/A
  • EPS Growth
  • GLAD N/A
  • CTKB N/A
  • EPS
  • GLAD 3.38
  • CTKB N/A
  • Revenue
  • GLAD $88,900,000.00
  • CTKB $196,035,000.00
  • Revenue This Year
  • GLAD N/A
  • CTKB $0.09
  • Revenue Next Year
  • GLAD $13.91
  • CTKB $7.45
  • P/E Ratio
  • GLAD $7.71
  • CTKB N/A
  • Revenue Growth
  • GLAD N/A
  • CTKB N/A
  • 52 Week Low
  • GLAD $21.96
  • CTKB $2.37
  • 52 Week High
  • GLAD $30.43
  • CTKB $7.63
  • Technical
  • Relative Strength Index (RSI)
  • GLAD 35.75
  • CTKB 53.78
  • Support Level
  • GLAD $26.06
  • CTKB $3.85
  • Resistance Level
  • GLAD $26.60
  • CTKB $4.23
  • Average True Range (ATR)
  • GLAD 0.37
  • CTKB 0.17
  • MACD
  • GLAD -0.03
  • CTKB -0.04
  • Stochastic Oscillator
  • GLAD 10.57
  • CTKB 40.70

About GLAD Gladstone Capital Corporation

Gladstone Capital Corp is an externally managed, closed-end, non-diversified management investment company. Its investment objectives are to, achieve and grow current income by investing in debt securities of established businesses that would provide stable earnings and cash flow to pay expenses, make principal and interest payments on its outstanding indebtedness, and make distributions to stockholders that grow over time; and provide its stockholders with long-term capital appreciation in the value of its assets by investing in equity securities of established businesses that can grow over time to permit it to sell its equity investments for capital gains.

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

Share on Social Networks: